Results 1 to 10 of about 52,243 (243)

Sources of Measurement Error in an ECG Examination: Implications for Performance-Based Assessments [PDF]

, 2004
Objective: To assess the sources of measurement error in an electrocardiogram (ECG) interpretation examination given in a third-year internal medicine clerkship. Design: Three successive generalizability studies were conducted.
Frerenchick, Gary, Solomon, David J
core   +1 more source

Radiofrequency ablation of the left atrial scar-related atrial flutter in a patient without prior ablative procedures

Heart Vessels and Transplantation, 2022
Atypical atrial flutter may develop in patients without prior cardiac ablations. In such cases, they may be related to the areas of spontaneous left atrial scarring.
Alexey Sergeev, Albert Akhobekov, Dmitriy Koblov, Abai Turdubaev   +3 more
doaj   +1 more source

Characterizing Recurrence Following Hybrid Ablation in Patients With Persistent Atrial Fibrillation

Journal of Patient-Centered Research and Reviews, 2020
Purpose: It is It is widely accepted that atrial fibrillation (AF) accounts for half of arrhythmia recurrences following endocardial catheter ablation of AF.
David C. Kress, Lynn Erickson, Tadele W. Mengesha, David Krum, Jasbir Sra   +4 more
doaj   +1 more source

Improved costs and outcomes with conscious sedation vs general anesthesia in TAVR patients: Time to wake up? [PDF]

, 2017
BackgroundTranscatheter aortic valve replacement (TAVR) has become a commonplace procedure for the treatment of aortic stenosis in higher risk surgical patients.
Aksoy, Olcay, Benharash, Peyman, Fernandez, Josue, Johansen, Daniel, Kwon, Murray, Patel, Komal D, Sareh, Sohail, Satou, Nancy, Shemin, Richard J, Suh, William, Toppen, William   +10 more
core   +3 more sources

Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study [PDF]

, 2018
Aims: To test the prognostic value of emerging biomarkers in the Reduction of Events by Darbepoetin Alfa in Heart Failure (RED-HF) trial. Methods and results: Circulating cardiac [N-terminal pro-B-type natriuretic peptide (NT-proBNP), and high ...
Alehagen, Arimoto, Balling, Bolignano, Cabassi, Dupont, Gaggin, Gravning, Grodin, Guisado Espartero, Haehling, Harrell, Jackson, Lassus, Lassus, Lok, Maisel, Maisel, McMurray, McMurray, Miller, Miller, Nagarajan, Park, Pascual-Figal, Pencina, Pencina, Pocock, Ponikowski, Rahimi, Rush, Shlipak, Swedberg, Tentzeris, Zamora   +34 more
core   +4 more sources

What Is the Optimal Digoxin Level? Challenging Case of Fetal Atrial Flutter Treatment in a Monochorionic Diamniotic Twin

Medicina, 2023
Background: Atrial flutter is an infrequent yet potentially fatal arrhythmia. Digoxin is the preferred first-line treatment for fetal atrial flutter due to its efficacy and favorable safety profile.
Soo Jung Kim, Hee Do Jeon, So-Yeon Shim, Yi-Seul Kim, Mi-Hye Park, Kyung A. Lee   +5 more
doaj   +1 more source

Virtualizing clinical cases of atrial flutter in a fast marching simulation including conduction velocity and ablation scars

Current Directions in Biomedical Engineering, 2015
Diagnosis of atrial flutter caused by ablation of atrial fibrillation is complex due to ablation scars. This paper presents an approach to replicate the clinically measured flutter circuit in a dynamic computer model.
Trächtler J., Oesterlein T., Loewe A., Poremba E., Luik A., Schmitt C., Dössel O.   +6 more
doaj   +1 more source

The incidence and risk factors for new onset atrial fibrillation in the PROSPER study [PDF]

, 2011
Aims Atrial fibrillation/flutter (AF) is the most common arrhythmia in older people. It associates with reduced exercise capacity, increased risk of stroke, and mortality. We aimed to determine retrospectively whether pravastatin reduces the incidence of
B. Buckley, Benjamin, Benjamin, D. J. Stott, Go, Grimsmo, H. Murray, Haywood, I. Ford, J. Shepherd, J. W. Jukema, Liakopoulos, Liu, N. Sattar, P. W. Macfarlane, R. G. J. Westendorp, Romhilt, Schnabel, Shepherd, Shepherd, Young-Xu   +20 more
core   +1 more source

Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A phase 2, randomized, sham-controlled trial [PDF]

, 2018
Background -In non-randomized, open-label studies, a transcatheter interatrial shunt device (IASD, Corvia Medical) was associated with lower pulmonary capillary wedge pressure (PCWP), less symptoms, and greater quality of life and exercise capacity in ...
Basuray, Anupam, Burkhoff, Daniel, Fail, Peter S., Feldman, Ted, Forde-McLean, Rhondalyn, Hummel, Scott L., Kahwash, Rami, Kaye, David M., Lilly, Scott, Litwin, Sheldon, Massaro, Joseph M., Mauri, Laura, Nielsen, Christopher D., Penicka, Martin, Petrie, Mark C., Ricciardi, Mark J., Shah, Sanjiv J., van der Harst, Pim   +17 more
core   +1 more source

The year in cardiology: arrhythmias and pacing. [PDF]

, 2020
During this last year, there has been much progress with regard to anticoagulant and ablation therapy for atrial fibrillation (AF). Apart from recently issued European Society of Cardiology Guidelines for the management of patients with supraventricular ...
Calkins, H, Camm, AJ, Lip, GYH, Schilling, R, Steffel, J   +4 more
core   +4 more sources